Hot Pursuit     18-Dec-24
Auro Pharma’s Telangana unit gets 2 USFDA observations
The inspection was conducted between 9 December and 17 December 2024.
The United States Food and Drug Administration (US FDA) inspected Unit-V, an API manufacturing facility, of Apitoria Pharma, a wholly owned subsidiary of Auro Pharma, situated at Pashamylaram Village, Patancheru Mandal, Sanga Reddy District, Telangana from 9 December to 17 December 2024.

The inspection closed with 2 observations. The observations are of procedural in nature and will be responded to within the stipulated time, stated the drug maker.

Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.

The pharma major reported 7.95% rise in consolidated net profit to Rs 817.38 crore on a 6.93% increase in revenue from operations to Rs 7,646.21 crore in Q2 FY25 over Q2 FY24.

Shares of Aurobindo Pharma gained 3.01% to Rs 1,250 on the BSE.

Previous News
  Auro Pharma Q3 PAT slides 10% YoY to Rs 846 crore
 ( Hot Pursuit - 07-Feb-25   12:47 )
  Aurobindo Pharma consolidated net profit declines 9.66% in the December 2024 quarter
 ( Results - Announcements 07-Feb-25   07:32 )
  Board of Aurobindo Pharma approves acquisition of 26% stake in a solar energy company
 ( Corporate News - 06-Feb-25   20:22 )
  Board of Aurobindo Pharma approves acquisition of 80% stake in Tergene Biotech
 ( Corporate News - 06-Feb-25   20:19 )
  Apitoria Pharma's Unit 2 completes USFDA inspection
 ( Corporate News - 28-Jan-25   12:15 )
  Aurobindo Pharma Ltd rises for third straight session
 ( Hot Pursuit - 20-Jan-25   13:06 )
  Aurobindo Pharma to table results
 ( Corporate News - 17-Jan-25   18:01 )
  Aurobindo Pharma Ltd slips for fifth straight session
 ( Hot Pursuit - 08-Jan-25   13:35 )
  Aurobindo Pharma Ltd up for third straight session
 ( Hot Pursuit - 31-Dec-24   13:05 )
  CuraTeQ Biologics receives UK MHRA approval for oncology biosimilar Bevqolva
 ( Corporate News - 23-Dec-24   16:13 )
  Auro Pharma gets UK MHRA nod for cancer drug
 ( Hot Pursuit - 21-Dec-24   15:20 )
Other Stories
  Cupid Q3 PAT jumps 25% to Rs 11 cr
  15-Feb-25   15:46
  AGS Transact Tech Q3 net loss widens to Rs 194 cr
  15-Feb-25   15:04
  Swan Energy Q3 PAT soars 406% YoY to Rs 583 cr
  15-Feb-25   12:45
  Genesys Intl Q3 PAT climbs 32% YoY to Rs 21 cr
  15-Feb-25   12:15
  PTC Industries Q3 PAT spurts 76% YoY to Rs 14 cr
  15-Feb-25   11:34
  RVNL Q3 PAT slides 13% YoY to Rs 311 crore
  15-Feb-25   10:47
  BHEL bags Rs 6,700 crore power project from Singareni Collieries
  15-Feb-25   09:48
  Mahindra & Mahindra's electric SUVs see 30,179 bookings on day 1
  15-Feb-25   09:32
  Reliance Industries acquires Lakadia B Power Transmission
  15-Feb-25   09:21
  Ethos rises after Q3 PAT climbs 15% YoY to Rs 29 cr
  14-Feb-25   15:12
Back Top